Eli Lilly Unusual Options Activity - Eli Lilly (NYSE:LLY)

Core Insights - Financial giants have shown a bearish sentiment towards Eli Lilly, with 51% of traders exhibiting bearish tendencies compared to 27% bullish [1] - The analysis of options trading indicates a significant focus on a price range between $520.0 and $1400.0 over the last three months [2] - Eli Lilly's options trading activity has revealed a total of 84 unusual trades, with a notable volume of puts and calls [1] Options Activity - The recent options activity includes 26 puts valued at $2,090,541 and 58 calls valued at $10,418,102, indicating a higher interest in calls despite the bearish sentiment [1] - A detailed overview of options activity shows various trades with different sentiments, including neutral and bearish positions [7] Company Overview - Eli Lilly specializes in neuroscience, cardiometabolic, cancer, and immunology, with key products such as Verzenio, Mounjaro, and Jardiance [8] - The current market position of Eli Lilly is reflected in expert ratings, with an average target price of $1195.8 from five analysts [9] Analyst Ratings - Analysts from Citigroup, Leerink Partners, BMO Capital, Morgan Stanley, and Cantor Fitzgerald have provided ratings ranging from Buy to Outperform, with target prices between $985 and $1500 [10] Current Market Status - As of the latest data, Eli Lilly's stock price is $1074.19, reflecting a decrease of 2.73% with a trading volume of 1,643,178 [12]